BioCentury
ARTICLE | Company News

Hyal deal

August 8, 1994 7:00 AM UTC

Imperial Pharmaceuticals Services Ltd. (U.K.) will develop topical acne drugs using HYALF’s hyaluronan induced targeting technology. Imperial will fund and manage product development and will select l...